ReviewFrontiers in oncology2023

Adverse reactions after treatment with dasatinib in chronic myeloid leukemia: Characteristics, potential mechanisms, and clinical management strategies.

Fang Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.